Literature DB >> 16682597

Nonarteritic anterior ischemic optic neuropathy and sildenafil.

Frederick W Fraunfelder, Howard D Pomeranz, Robert A Egan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16682597     DOI： 10.1001/archopht.124.5.733

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN： 0003-9950


× No keyword cloud information.
  5 in total

1.  Sequential, non-arteritic anterior ischemic optic neuropathy in patients taking sildenafil: a report of ten cases.

Authors:  Alberto Galvez-Ruiz; Nawal Arishi
Journal:  Saudi J Ophthalmol       Date:  2013-07-22

2.  Post-marketing surveillance of ischaemic optic neuropathy in male veterans co-prescribed phosphodiesterase-5 inhibitors with organic nitrates or alpha-blockers.

Authors:  Dustin D French; Curtis E Margo
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond.

Authors:  Hossein A Ghofrani; Ian H Osterloh; Friedrich Grimminger
Journal:  Nat Rev Drug Discov       Date:  2006-08       Impact factor: 84.694

Review 4.  Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.

Authors:  R Sadovsky; G B Brock; S W Gutkin; S Sorsaburu
Journal:  Int J Clin Pract       Date:  2009-08       Impact factor: 2.503

5.  Chronic low dosing of phosphodiesterase type 5 inhibitor for erectile dysfunction.

Authors:  Hyun Hwan Sung; Sung Won Lee
Journal:  Korean J Urol       Date:  2012-06-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.